Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Tiotropium (18 Mcg) Once Daily Via the HandiHaler® in Patients With Chronic Obstructive Pulmonary Disease (COPD)

ClinicalTrials.gov ID: NCT00274547

Public ClinicalTrials.gov record NCT00274547. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 7:34 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, Parallel Group Trial Assessing the Proportion of Patients Experiencing an Exacerbation and Proportion of Patients Hospitalized for an Exacerbation Over 6 Months During Treatment With Tiotropium 18 Mcg Capsule Once Daily in Patients With COPD in a Veterans Affairs Setting

Study identification

NCT ID
NCT00274547
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Boehringer Ingelheim
Industry
Enrollment
1,829 participants

Conditions and interventions

Interventions

  • Tiotropium Drug

Drug

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2001
Primary completion
Jan 31, 2003
Completion
Not listed
Last update posted
Oct 31, 2013

Started 2001

United States locations

U.S. sites
26
U.S. states
18
U.S. cities
26
Facility City State ZIP Site status
Boehringer Ingelheim Investigational Site Birmingham Alabama
Carl T. Hayden VA Medical Center Phoenix Arizona
Southern Arizona VA Health Care System Tuscon Arizona
VA Long Beach Healthcare System Long Beach California
Boehringer Ingelheim Investigational Site Palo Alto California
Respiratory Diseases (111A) Bay Pines Florida
J. Hillis Miller Health Center Gainesville Florida
Veteran Affairs Medical Center Hines Illinois
Veterans Affairs Medical Center North Chicago Illinois
Boehringer Ingelheim Investigational Site Indianapolis Indiana
Boehringer Ingelheim Investigational Site Lexington Kentucky
4720 I-10 Service Road Metairie Louisiana
Boehringer Ingelheim Investigational Site Boston Massachusetts
Veteran Affairs Medical Center Minneapolis Minnesota
Boehringer Ingelheim Investigational Site Kansas City Missouri
Boehringer Ingelheim Investigational Site Omaha Nebraska
Boehringer Ingelheim Investigational Site Reno Nevada
Boehringer Ingelheim Investigational Site Buffalo New York
Bronx VA Medical Center New York New York
Boehringer Ingelheim Investigational Site Durham North Carolina
Dallas VAMC Dallas Texas
Veterans Affairs Medical Center Houston Texas
Boehringer Ingelheim Investigational Site San Antonio Texas
Boehringer Ingelheim Investigational Site Salt Lake City Utah
Hampton VA Medical Center Hampton Virginia
Hunter Holmes McGuire Medical Center Richmond Virginia

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00274547, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 31, 2013 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00274547 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →